Mind Medicine MindMed Inc. buy Royal Bank of Canada
Start price
29.02.24
/
50%
€5.23
Target price
28.02.25
€13.89
Performance (%)
67.46%
Price
18:15
€8.75
Summary
This prediction is currently active. With a performance of 67.46% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 28.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Mind Medicine MindMed Inc. | 12.777% | 12.777% |
| iShares Core DAX® | -0.992% | -3.231% |
| iShares Nasdaq 100 | -0.225% | -3.339% |
| iShares Nikkei 225® | -0.736% | -7.859% |
| iShares S&P 500 | -0.509% | -2.979% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Mind Medicine MindMed Inc. diskutieren
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its price target raised by analysts at Royal Bank of Canada from $14.00 to $15.00. They now have an "outperform" rating on the stock.
Ratings data for MNMD provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Mind Medicine MindMed Inc.
Mind Medicine MindMed Inc.
Start price
Target price
Perf. (%)
€2.50
23.10.23
23.10.23
€6.57
23.10.24
23.10.24
251.20%
18:15
18:15
Mind Medicine MindMed Inc.
Start price
Target price
Perf. (%)
€3.95
04.08.23
04.08.23
€6.34
04.08.24
04.08.24
122.39%
18:15
18:15
Mind Medicine MindMed Inc.
Start price
Target price
Perf. (%)
€2.84
13.03.23
13.03.23
€4.66
13.03.24
13.03.24
193.66%
14.03.24
14.03.24